Publicacións en colaboración con investigadores/as de Consiglio Nazionale delle Ricerche (9)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma

    Leukemia, Vol. 35, Núm. 3, pp. 823-834

2020

  1. MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

  2. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2015

  1. Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014

    Journal of Translational Medicine, Vol. 13, Núm. 1

2014

  1. Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013

    Journal of Translational Medicine, Vol. 12, Núm. 1

2000

  1. Dissipative dynamics of an open Bose-Einstein condensate

    BOSE-EINSTEIN CONDENSATES AND ATOM LASERS